Belite Bio Chief Scientific Officer Nathan L. Mata Sells 1,000 ADS Shares in Multiple Transactions

This SEC Form 4 filing reports that Nathan L. Mata, Chief Scientific Officer of Belite Bio, Inc. (NASDAQ: BLTE), sold a total of 1,000 American Depositary Shares (ADS) on May 1, 2026, through eight separate transactions. The sales were executed at weighted average prices ranging from $153.8942 to $160 per share, with the transactions occurring under a Rule 10b5-1 trading plan adopted on December 10, 2025. Following these sales, Mata's direct ownership position decreased from 4,666 ADS to 3,666 ADS. The filing notes that each ADS represents one ordinary share of the company. These transactions represent routine insider trading activity conducted under a pre-established trading plan.